Home / Health / Join VA and the White House Cancer Cabinet Community Conversation
Join VA and the White House Cancer Cabinet Community Conversation
Mark your calendar for July 26
On Tuesday, July 26, VA health leaders, along with representatives from private and public health care organizations, will host a Cancer Cabinet Community Conversation as part of the White House Office of Science and Technology Policy’s Cancer Moonshot Initiative. The conversation will focus on the agency’s cutting edge prostate cancer precision oncology program to advance cancer treatment.
Cancer Cabinet Community Conversation
VA’s Cancer Cabinet Community Conversation roundtable will be held at Noon EST on July 26, and the public is welcome to join us via YouTube. (If you’re not able to attend the live event online, the video will remain on Youtube afterward, at the same link.)
The following experts and Veterans will speak about improvements in the treatment of prostate cancer and other genitourinary cancers, among the most commonly diagnosed cancers for Veterans:
Dr. Steven Lieberman, deputy Under Secretary for Health Performing the Delegable Duties of Under Secretary for Health, Veterans Health Administration
Dr. Charles Ryan, president & CEO Prostate Cancer Foundation
Dr. Carolyn Clancy, assistant Under Secretary for Health for Discovery, Education, and Affiliate Networks, Veterans Health Administration
U.S. Army Veteran Patrick Dennison
Dr. Matthew Rettig, medical oncologist, VA Greater Los Angeles/ UCLA Jonsson Comprehensive Cancer Center
Dr. Isla P. Garraway, urologic oncologist, VA Greater Los Angeles/ UCLA Jonsson Comprehensive Cancer Center
U.S. Marine Corps Veteran David Seidl
Dr. Julie Graff, medical oncologist, VA Portland/Knight Cancer Institute
Dr. Bruce Montgomery, medical oncologist, VA Puget Sound/Fred Hutchinson Cancer Center
Make sure to set a reminder to tune into the Cancer Cabinet Community Conversation on Prostate Cancer and Genitourinary Cancers.
VA has a network of medical centers and a range of clinical trials providing state-of-the-art precision oncology care for Veterans with prostate cancer and other genitourinary cancers through a partnership with the Prostate Cancer Foundation.